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myocardial infarction and cerebrovascular stroke, while 
the number of studies had detected that early diagnosis 
and treatment of high-blood pressure led to better 
quality of life and increased longevity.[2-8]
Thus, World Hypertension Day also reminds us of the 
following facts;
High-blood pressure is largely preventable and remains 
a constant threat to the health
High-blood pressure is easy to screen
Efficient lifestyle modification and drug treatments are 
available that could control high-blood pressure in many 
countries.[1-4,7-10]
Chronic renal failure is a worldwide public health problem, 
and high-blood pressure is one the most important cause 
of dame to the kidneys. The incidence and prevalence 
of renal failure are increasing and are associated with 
poor consequences and high cost. The activity of the 
renin-angiotensin system (RAS) plays a central role in 
the pathogenesis of chronic renal failure, high-blood 
pressure and cardiovascular complications.[10-20] Hence, as 
a nephrology point of view, targeting the RAS is a logical 
therapeutic approach. In fact interruption of the RAS using 
type 1 angiotensin II receptor blockers or angiotensin-
converting enzyme inhibitors alone or in combination, has 
become an appropriate therapeutic strategy to decrease 
blood pressure, proteinuria and most importantly to slow 
the progression of chronic renal failure.[10-20]
The concept of kidney protection during the treatment 
of high-blood pressure has evolved significantly, driven 
by improved understanding of the pathophysiology 
of chronic kidney disease and the advent of novel 
treatment options.[12-18] Glomerular hyperfiltration, 
high-blood pressure and proteinuria represent key 
mediators of chronic kidney disease progression. It 
is increasingly documented that high-blood pressure 
may actually be pathological and etiological in 
chronic kidney disease progression, and many cases 
is not symptomatic.[12-18] It commences a sequence of 
processes, involving activation of proinflammatory and 
sclerosing signaling pathways in the glomeruli with 
transmission of the process to the tubulointerstitial 
area and progression to end-stage renal failure. 
Thus, it seems that any modality for the treatment of 
hypertension should base on kidney protection too.
[10-22] As World Hypertension Day remember us, still 
remains a great deal of work to be conducted. As 
mentioned above, working with other health staffs and 
family physicians, will play a great role in certifying 
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Sir,
The World Hypertension Day celebrates 17th of May 
of each year by focusing on an important global health 
issue.[1] For World Hypertension Day 2014, they have 
selected “know your blood pressure” as the theme.
Many surveys from various countries throughout the 
world pointed out that the public’s awareness of their 
blood pressure levels was very inadequate.[1,2] Even 
in highly developed, resource-rich populations with 
high-quality health care systems, alertness of high-
blood pressure was not enough. While in many of the 
developing countries, there was transition from infectious 
to some other chronic diseases; however, the prevalence 
of high-blood pressure is increasing in their population.
[1-4] Together, public alertness of high-blood pressure in 
the low- and middle-income countries is quite miserable, 
while many surveys stated that the high-blood pressure 
is the leading cause of death worldwide.[2-5]
World Hypertension Day’s focus on them as “know your 
blood pressure “in 2014 is intended:
To raise recognition of the causes and consequences of 
high-blood pressure
To provide information on how to prevent high-blood 
pressure and associated complications[1-6]
To incite persons to check their blood pressure and to 
follow the advice of health care professionals
To incite self-care to prevent high-blood pressure
To make blood pressure assessment inexpensive to all[1,3-8]
High-blood pressure is caused by a mixture of genetic 
predisposition and an unhealthy diet high in saturated 
fats, free sugars and sodium. In fact, epidemiological 
investigations have clearly detected that high-blood 
pressure is a “silent killer,” with no warning signs. 
Hence, knowing that one’s blood pressure is elevated 
permits that individual to take some action to abate the 
rising blood pressure, therefore, preventing potential 
target-organ damage, comprising renal failure, 
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individuals benefit from optimum blood pressure levels 
in the future. Noticeably, with an aging population and an 
epidemic of obesity, the prevalence of high-blood pressure 
will increase. We need to redouble our attempts to prevent 
high-blood pressure by encouraging for our governments 
to introduce healthy public policies and by inciting our 
patients to live healthier lives, maintain ideal weight, 
exercise regularly, avoiding excess sugary drinks, avoid 
smoking, and reduce the sodium of the diet.[1-8,19]
On the other hand by improved screening and diagnostic 
attempts, and judicious use of antihypertensive using 
renoprotective drugs, we will continue to reduce the incidence 
of strokes, heart failure and cardiac attacks, therefore, our 
patients will able to enjoy of their advanced age more fully.[17-22]
Finally as a clinician, there is many works to do, for all of us 
involved in high-blood pressure management and health care. 
Voluntary health agencies, nongovernmental organizations and 
professional societies can focus more efforts on serving patients, 
and health professionals have better tools for managing high-
blood pressure. Furthermore, governments undoubtedly have 
a role in adopting health policies that support prevention of 
disease and using health resources wisely in this issue. Health 
policies are making the obtainable therapies accessible to all 
people, which can be a key step in improving our current 
condition. And lastly, persons, including patients, researchers 
and clinicians, can commit to doing all in their ability to improve 
high-blood pressure care.[17-25]
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